Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.
Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.
DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
NUA Surgical develops a specialised surgical retractor to make C-Sections a safer and superior surgery.
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Shinobi Therapeutics is a biotech company that develops immune-evasive iPS cell therapies for cancer treatment.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
Onera Health is a global leader in sleep diagnostics and monitoring.
LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
EQT Life Sciences has invested in 81 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EQT Life Sciences's top investment sectors include Health Care, Biotechnology, Pharmaceutical, Therapeutics, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Splice Bio received $135.0M in a Series B round. EQT Life Sciences's total known invested capital is $4.5B.
EQT Life Sciences's average investment size is $72.3M across its portfolio of 81 companies.
Recent EQT Life Sciences portfolio additions include Cyted, SNIPR Biome, Splice Bio, Mosanna Therapeutics, Xilis. These companies were founded in 2020 or later.